Operating Lease, Payments in USD of Crown Electrokinetics Corp. from Q1 2022 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Crown Electrokinetics Corp. quarterly/annual Operating Lease, Payments history and change rate from Q1 2022 to Q1 2025.
  • Crown Electrokinetics Corp. Operating Lease, Payments for the quarter ending 31 Mar 2025 was $228K, a 52.9% decline year-over-year.
  • Crown Electrokinetics Corp. annual Operating Lease, Payments for 2024 was $912K, a 32.9% increase from 2023.
  • Crown Electrokinetics Corp. annual Operating Lease, Payments for 2023 was $686K, a 4.59% decline from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Crown Electrokinetics Corp. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $228K -$256K -52.9% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q1 2024 $484K +$292K +152% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q2 2023 $688K $119K -$70K -37% 01 Apr 2023 30 Jun 2023 10-Q 25 Aug 2023
Q1 2023 $758K $192K +$39K +25.5% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024
Q4 2022 $719K $187K 01 Oct 2022 31 Dec 2022 10-K 31 Mar 2023
Q3 2022 $190K 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $189K 01 Apr 2022 30 Jun 2022 10-Q 25 Aug 2023
Q1 2022 $153K 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023

Crown Electrokinetics Corp. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $912K +$226K +32.9% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 $686K -$33K -4.59% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 $719K 01 Jan 2022 31 Dec 2022 10-K 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.